Gilead Sciences, Inc.GILDNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR+10.0%
5Y CAGR+10.9%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+10.0%/yr
vs +7.5%/yr prior
5Y CAGR
+10.9%/yr
Consistent
Acceleration
+2.5pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.75 | +13.3% |
| 2024 | 5.96 | +34.6% |
| 2023 | 4.43 | -12.7% |
| 2022 | 5.07 | +17.2% |
| 2021 | 4.33 | +7.6% |
| 2020 | 4.02 | +9.8% |
| 2019 | 3.66 | -3.5% |
| 2018 | 3.80 | -17.1% |
| 2017 | 4.58 | -9.8% |
| 2016 | 5.08 | - |